Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits.
The objective of this study was to evaluate the potential of collagen sponge incorporating transforming growth factor-beta1 (TGF-beta1) to enhance bone repair. The collagen sponge was prepared by freeze-drying aqueous foamed collagen solution. Thermal cross-linking was performed in a vacuum at 140 degrees C for periods ranging from 1 to 48 h to prepare a number of fine collagen sponges. When collagen sponges incorporating 125I-labeled TGF-beta1 were placed in phosphate-buffered saline (PBS) solution at 37 degrees C, a small amount of TGF-beta1 was released for the first hour, but no further release was observed thereafter, irrespective of the amount of cross-linking time the sponges had received. Collagen sponges incorporating 125I-labeled TGF-beta1 or simply labeled with 125I were implanted into the skin on the backs of mice. The radioactivity of the 125I-labeled TGF-beta1 in the collagen sponges decreased with time; the amount of TGF-beta1 remaining dependent on the cross-linking time. The in vivo retention of TGF-beta1 was longer in those sponges that had been subjected to longer cross-linking times. The in vivo release profile of the TGF-beta1 was matched with the degradation profile of the sponges. Scanning electron microscopic observation revealed no difference in structure among sponges subjected to different cross-linking times. The TGF-beta1 immobilized in the sponges was probably released in vivo as a result of sponge biodegradation because TGF-beta1 release did not occur in in vitro conditions in which sponges did not degrade. We applied collagen sponges incorporating 0.1 microg of TGF-beta1 to skull defects in rabbits in stress-unloaded bone situations. Six weeks later, the skull defects were covered by newly formed bone, in marked contrast to the results obtained with a TGF-beta1 free empty collagen sponge and 0.1 microg of free TGF-beta1. We concluded that the collagen sponges were able to release biologically active TGF-beta1 and were a promising material for bone repair.
Ueda
Hiroki
H
Institute for Frontier Medical Sciences, Kyoto University, Japan.
Hong
Liu
L
Yamamoto
Masaya
M
Shigeno
Keiji
K
Inoue
Masatoshi
M
Toba
Toshinari
T
Yoshitani
Makoto
M
Nakamura
Tatsuo
T
Tabata
Yasuhiko
Y
Shimizu
Yasuhiko
Y
D000818:Animals; D001672:Biocompatible Materials; D003094:Collagen / Q000648:ultrastructure; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D005260:Female; D017102:Fracture Healing / Q000187:drug effects*; D008422:Materials Testing; D051379:Mice; D008855:Microscopy, Electron, Scanning; D011817:Rabbits; D011994:Recombinant Proteins / Q000008:administration & dosage; D012887:Skull Fractures / Q000188:drug therapy / Q000473:pathology; D015503:Surgical Sponges; D016212:Transforming Growth Factor beta / Q000008:administration & dosage*; D053773:Transforming Growth Factor beta1
D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D011994:Recombinant Proteins; C508961:Tgfb1 protein, mouse; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D003094:Collagen